Quick Answer
RxSight, Inc. reported Total Assets of $311.81 million for fiscal year 2025.
RxSight, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $311.81M | -2.1% |
| 2024 | $318.56M | +74.5% |
| 2023 | $182.55M | +21.6% |
| 2022 | $150.16M | -22.1% |
| 2021 | $192.72M | +91.4% |
| 2020 | $100.68M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $308.53M | -0.6% | -0.2% |
| June 30, 2025 | $309.01M | +1.1% | -1.3% |
| March 31, 2025 | $313.04M | +70.9% | -1.7% |
| December 31, 2024 | $318.56M | +74.5% | +2.6% |
| September 30, 2024 | $310.47M | +70.7% | +1.6% |
| June 30, 2024 | $305.50M | +56.5% | +66.8% |
| March 31, 2024 | $183.16M | -9.6% | +0.3% |
| December 31, 2023 | $182.55M | +21.6% | +0.4% |
- RxSight, Inc. showed a decrease of -2.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, RxSight, Inc.’s total assets has grown by 209.7% (from $100.68 million to $311.81 million).
- The most recent figure is from RxSight, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: